More from the blog
- About us
- Dementia info
- Living with dementia
- Our scientists
- Our supporters
It’s been great to hear supporters viewing the postponement of their event as an opportunity to use the time to raise even more money for dementia research and smash their fundraising targets. It’s brilliant to know our supporters are finding a way to continue to support our work in these extraordinary times.
This latest data offers a glimmer of hope for gantenerumab. The decrease in protein levels has led the researchers and the pharmaceutical company Roche to now invite the participants to take part in an open-label extension.
Although Alzheimer’s is the leading cause of dementia, vascular dementia affects 150,000 people in the UK, accounting for one in five of all dementia cases.
We hatched a plan to make sure that this year’s conference went ahead, but safely in light of the current coronavirus outbreak. It led to a huge social media effort to recreate the conference virtually on Twitter.
We’re thrilled to announce that we’re partnering with Alzheimer’s Research UK, one of the world’s leading dementia research charities dedicated to diagnosis, prevention, treatment and cure.
Amy Lloyd wins the 2020 award, which would ordinarily have been presented at our annual Research Conference that was due to take place in Wales this month.
People with dementia are likely to be particularly vulnerable to this virus so it is especially important that they and those around them take what steps they can to avoid transmission.
We’re acutely aware of the impact the outbreak will be having on people with dementia and their families, exacerbating an already unprecedented situation. Our hearts go out to everyone in such circumstances.
To mark Rare Disease Day we will discuss some of the rarer causes of dementia, providing information about what causes them and how they can be diagnosed.
Five years on from the national launch of Join Dementia Research, we look back at the service’s incredible impact and some of the exciting research taking place that you could get involved in.
The Early Detection of Neurodegenerative diseases (EDoN) initiative is spearheaded by Alzheimer’s Research UK and brings together 14 leading research and support organisations, working to develop innovative ways to pick up these diseases in the brain years before the symptoms of dementia start.
It’s a fantastic way to fundraise and engage your local community.
Primary progressive aphasia (PPA) is a condition caused by damage to parts of the brain that control our personality, emotions, language and behaviour.
It has certainly been a time of political turbulence. New governments bring new opportunities – and through its pledges, this one has given renewed hope to people affected by dementia. But we need more than hope: now we need action.
Most people know that smoking leads to poor health and a substantially increased risk of cancer and lung disease. But what’s the link to dementia?
This is our journey to a dementia diagnosis and illustrates why we need more research into quick and accurate diagnoses. It would’ve made such a difference to our lives.
Dr Cath Mummery aims to answer your questions about lumbar punctures, what the procedure involves and why it is used.
Would you want to know if you or a loved one had Alzheimer’s – a disease that currently has no treatments to slow, stop or prevent it – before you developed symptoms? This is understandably a frightening and tough question to answer.
The votes have been cast, and the results are in: the Conservatives will form the UK’s next government. So what will this mean for dementia research?
Research is making progress, and the last 12 months have seen a number of important new developments in the global effort to overcome dementia.
This International Volunteer Day, we asked Alzheimer’s Research UK Shropshire Fundraising Group leader Katie Foster to give an insight into her year in volunteering.
What if you could support groundbreaking dementia research while you get your home ready for Christmas, all without spending anything extra?
For many people, health is their top priority. And we know that dementia research is crucial for protecting the nation’s health.
Alzheimer’s Research UK’s Chief Medical Officer will help shape our emerging priority areas, including the development of new tools to improve the very early identification of diseases and ensuring swift access to any new life-changing treatments within the NHS.